salmeterol and fluticasone propionate inhalation ip : AIRFLOW 50 INH

AIRFLOW 50 is a highly effective combination inhalation therapy formulated with Salmeterol and Fluticasone Propionate, two clinically proven agents used for the long-term management of asthma and Chronic Obstructive Pulmonary Disease (COPD). This dual-action formula provides both bronchodilation and anti-inflammatory effects, offering comprehensive control over respiratory symptoms such as shortness of breath, wheezing, coughing, and chest tightness.

Salmeterol is a long-acting beta-agonist (LABA) that works by relaxing the muscles in the airways, allowing easier breathing and improving airflow to the lungs. Fluticasone Propionate, on the other hand, is a corticosteroid that helps reduce airway inflammation, swelling, and irritation, thereby preventing asthma attacks and flare-ups.

Manufactured using advanced inhalation technology, AIRFLOW 50 delivers medication directly to the lungs for fast, effective, and targeted relief. Its consistent dosing ensures steady symptom control, making it an ideal choice for patients who require ongoing respiratory therapy.

Uses

AIRFLOW 50 (Salmeterol and Fluticasone Propionate Inhalation IP) is primarily used for:

1. Asthma Maintenance Therapy:
   Helps control and prevent asthma symptoms such as wheezing, shortness of breath, and chest tightness by keeping the airways open and reducing inflammation.

2. Chronic Obstructive Pulmonary Disease (COPD):
   Provides long-term control and reduction of symptoms like chronic cough and difficulty breathing associated with COPD, chronic bronchitis, or emphysema.

3. Prevention of Asthma Attacks:
   Regular use reduces the frequency and intensity of asthma episodes, allowing patients to live an active, symptom-free life.

4. Improved Lung Function:
   Increases airflow to the lungs and enhances oxygen intake, improving overall respiratory health.

AIRFLOW 50 is not a rescue inhaler for sudden breathing problems — it is designed for long-term management and prevention of respiratory symptoms.

Benefits

1. Dual-Action Mechanism:
   Combines the bronchodilator effect of Salmeterol with the anti-inflammatory power of Fluticasone for complete respiratory control.

2. Long-Lasting Symptom Relief:
   One dose provides up to 12 hours of continuous relief, ensuring improved breathing throughout the day and night.

3. Reduces Frequency of Attacks:
   Regular use helps prevent severe asthma attacks and reduces the need for emergency medication.

4. Improves Breathing Efficiency:
   Opens up airways and reduces inflammation, improving lung function and overall breathing capacity.

5. Targeted Delivery System:
   Direct inhalation ensures quick action at the site of problem — the lungs — minimizing systemic side effects.

6. Enhances Quality of Life:
   Helps patients regain control over daily activities without being restricted by chronic breathing issues.

7. Clinically Proven Safety:
   Backed by extensive clinical research, AIRFLOW 50 offers a safe and effective treatment option for asthma and COPD management.

Dosage

• Recommended Dose:
  The usual adult dose is one inhalation twice daily, preferably once in the morning and once in the evening, or as directed by your physician.
  
  

• How to Use:
  
  

• Shake the inhaler well before use.

• Exhale completely, place the mouthpiece between your lips, and press the inhaler while inhaling deeply.

• Hold your breath for a few seconds to allow the medicine to reach deep into the lungs.

• Exhale slowly and rinse your mouth with water afterward to prevent oral infections.
  
  

• Important Points:
  
  

• Do not exceed the recommended dose.

• Continue regular use even if you feel better.

• Do not stop using AIRFLOW 50 suddenly without consulting your doctor.

• Keep a rescue inhaler (such as salbutamol) for sudden asthma attacks.

Following your doctor’s prescribed dosage schedule ensures consistent symptom control and long-term respiratory stability.

Side Effects

While AIRFLOW 50 is generally well-tolerated, some users may experience mild or temporary side effects, including:

• Throat irritation or hoarseness

• Headache or dizziness

• Nausea or upset stomach

• Cough or dry mouth

• Mild tremors or restlessness

• Oral fungal infection (thrush)

Rare but serious side effects may include:

• Allergic reactions like rash, swelling, or difficulty breathing

• Worsening of breathing problems immediately after inhalation

• Vision problems or increased intraocular pressure

• Irregular heartbeat or palpitations

To minimize side effects:

• Always rinse your mouth after each use.

• Do not use the inhaler more frequently than prescribed.

• Report any unusual symptoms to your healthcare provider immediately.

Conclusion

Salmeterol and Fluticasone Propionate Inhalation IP is a trusted and effective dual-therapy inhaler for long-term management of asthma and COPD. By combining a bronchodilator and an anti-inflammatory corticosteroid, it provides complete respiratory relief — improving airflow, reducing inflammation, and preventing severe attacks.

Regular use of AIRFLOW 50 under medical supervision can help patients breathe easier, stay active, and live a healthier life free from constant respiratory distress. Its targeted inhalation delivery ensures maximum effectiveness with minimal side effects, making it a preferred choice for both physicians and patients seeking reliable control over chronic lung conditions.